Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway

  • Authors:
    • Fengyun Dong
    • Hu Tian
    • Suhua Yan
    • Liqun Li
    • Xiaofeng Dong
    • Fuhai Wang
    • Jie Li
    • Changsheng Li
    • Zhiqun Cao
    • Xiaochun Liu
    • Ju Liu
  • View Affiliations

  • Published online on: March 16, 2015     https://doi.org/10.3892/ijmm.2015.2140
  • Pages: 1381-1387
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Disrupting tumor angiogenesis serves as an important strategy for cancer therapy. Dihydroartemisinin (DHA), a semi‑synthetic derivative of artemisinin, has exhibited potent anti‑angiogenic activity. However, the molecular mechanisms underlying this effect have not been fully understood. The present study aimed to investigate the role of DHA on endothelial cell proliferation, the essential process in angiogenesis. Human umbilical vein endothelial cells (HUVECs) treated with DHA were examined for proliferation, apoptosis and activation of the extracellular signal‑regulated kinase (ERK) signaling pathway. Proliferation of HUVECs was inhibited by 20 µM DHA without induction of apoptosis. DHA also reduced the phosphorylation of ERK1/2, and downregulated the mRNA and protein expression of ERK1/2 in HUVECs. In addition, DHA suppressed the transcription and protein expression of ERK1/2 downstream effectors c‑Fos and c‑Myc. Electrical cell‑substrate impedance sensing real‑time analysis demonstrated that ERK signaling inhibitor PD98059 comprises the anti‑proliferative effects of DHA. Thus, DHA inhibits endothelial cell proliferation by suppressing the ERK signaling pathway. The present study strengthened the potential of DHA as an angiogenesis inhibitor for cancer treatment.
View Figures
View References

Related Articles

Journal Cover

May-2015
Volume 35 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dong F, Tian H, Yan S, Li L, Dong X, Wang F, Li J, Li C, Cao Z, Liu X, Liu X, et al: Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway. Int J Mol Med 35: 1381-1387, 2015
APA
Dong, F., Tian, H., Yan, S., Li, L., Dong, X., Wang, F. ... Liu, J. (2015). Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway. International Journal of Molecular Medicine, 35, 1381-1387. https://doi.org/10.3892/ijmm.2015.2140
MLA
Dong, F., Tian, H., Yan, S., Li, L., Dong, X., Wang, F., Li, J., Li, C., Cao, Z., Liu, X., Liu, J."Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway". International Journal of Molecular Medicine 35.5 (2015): 1381-1387.
Chicago
Dong, F., Tian, H., Yan, S., Li, L., Dong, X., Wang, F., Li, J., Li, C., Cao, Z., Liu, X., Liu, J."Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway". International Journal of Molecular Medicine 35, no. 5 (2015): 1381-1387. https://doi.org/10.3892/ijmm.2015.2140